» Articles » PMID: 21724252

The Effect of Decellularized Bone/bone Marrow Produced by High-hydrostatic Pressurization on the Osteogenic Differentiation of Mesenchymal Stem Cells

Overview
Journal Biomaterials
Date 2011 Jul 5
PMID 21724252
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Decellularized bone/bone marrow was prepared to provide a microenvironment mimicking that of the bone marrow for three-dimensional culture in vitro. Bone/bone marrows were hydrostatically pressed at 980 MPa at 30 °C for 10 min to dismantle the cells. Then, they were washed with EGM-2 and further treated in an 80% EtOH to remove the cell debris and lipid, respectively. After being rinsed and shaken with PBS again, treated bone/bone marrows were stained with hematoxylin and eosin (H-E) to assess the efficacy of decellularization. Cells were determined to have been completely removed through H-E staining of their sections and DNA quantification. Rat mesenchymal stem cells (rMSCs) were seeded on the decellularized bone/bone marrows and cultured for 21 days. The adhesion of rMSCs on or into decellularized bone/bone marrows was confirmed and proliferated over time in culture. The osteogenic differentiation effect of decellularized bone/bone marrows on rMSCs in the presence or absence of dexamethasone was investigated. Decellularized bone/bone marrows without dexamethasone significantly increased alkaline phosphatase (ALP) activity, indicating promoted osteogenic differentiation of rMSCs. In an animal study, when decellularized bone/bone marrows were implanted into the rat subcutaneous, no immune reaction occurred and clusters of the hematopoietic cells could be observed, suggesting the decellularized bone/bone marrows can provide a microenvironment in vivo.

Citing Articles

Optimization strategies for mesenchymal stem cell-based analgesia therapy: a promising therapy for pain management.

Zhang J, Wu P, Wen Q Stem Cell Res Ther. 2024; 15(1):211.

PMID: 39020426 PMC: 11256674. DOI: 10.1186/s13287-024-03828-8.


Biological parameters for quality evaluation of allografts from the Brazilian National Institute of Traumatology and Orthopedics tissue bank.

Prinz R, da Rocha L, Eirado T, da Silva Pinto J, Matheus Guimaraes J, Fogagnolo F Cell Tissue Bank. 2024; 25(2):625-632.

PMID: 38367054 DOI: 10.1007/s10561-024-10125-4.


Evaluation of the osteogenic potential of demineralized and decellularized bovine bone granules following implantation in rat calvaria critical-size defect model.

Al Qabbani A, Aghila Rani K, AlKawas S, Abdul Hamid S, Yap Abdullah A, Samsudin A PLoS One. 2023; 18(12):e0294291.

PMID: 38127838 PMC: 10734957. DOI: 10.1371/journal.pone.0294291.


Decellularized extracellular matrix biomaterials for regenerative therapies: Advances, challenges and clinical prospects.

Golebiowska A, Intravaia J, Sathe V, Kumbar S, Nukavarapu S Bioact Mater. 2023; 32:98-123.

PMID: 37927899 PMC: 10622743. DOI: 10.1016/j.bioactmat.2023.09.017.


Microenvironment-targeted strategy steers advanced bone regeneration.

Hao S, Wang M, Yin Z, Jing Y, Bai L, Su J Mater Today Bio. 2023; 22:100741.

PMID: 37576867 PMC: 10413201. DOI: 10.1016/j.mtbio.2023.100741.